<DOC>
	<DOCNO>NCT02707783</DOCNO>
	<brief_summary>The aim study feasibility complete coronary revascularization bioresorbable vascular scaffold ( BVS ) implantation assessment treatment outcome group consecutive patient stable unstable angina Russian population . The hypothesis registry study : 1 ) Complete coronary revascularization BVS implantation feasible perform least 70 percent patient population stable unstable angina qualify revascularization coronary angiography , 2 ) Complete revascularization BVS safe effective revascularization standard BMS ( Bare Metal Stent BMS/ Drug Eluting Stent DES stent implantation ( publish literature comparators match population ) . Up 2500 patient enrol 13 Russian high volume invasive cardiology centre . 12 month clinical observation 5-year clinical follow-up expect .</brief_summary>
	<brief_title>Feasibility Outcomes Complete Coronary Revascularization Using BVS All-comer Patients With Angina</brief_title>
	<detailed_description>Study design : Data regard consecutive patient qualify revascularization ( PCI Percutaneous Coronary Intervention CABG Coronary Artery Bypass Grafting ) collect prospective study . Information regard revascularization strategy collect detailed information concern PCI procedure . In case PCI BVS stent implantation ( BMS or/and metallic DES ) information collect study contain least : - Reason BVS implant - Final result baseline treatment - Acute long-term outcome treatment ( 12 month clinical observation ) ; NB . 5-year clinical follow-up also expect . The enrollment phase registry expect last long 12 month .</detailed_description>
	<mesh_term>Angina Pectoris</mesh_term>
	<criteria>Patient characteristic Age &gt; 18 year Able willing give inform consent Willing comply specify followup evaluation Clinical manifestation coronary artery disease : stable angina unstable angina Indications coronary revascularization Patient characteristic Acute Myocardial infarction Cardiogenic shock Any reason patient 's inability comply 12month double antiplatelet therapy ( DAPT ) Absolute contraindication DES BVS implantation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>stable unstable angina</keyword>
	<keyword>bioresorbable vascular scaffold</keyword>
	<keyword>BVS</keyword>
	<keyword>PCI</keyword>
</DOC>